-
ECONOMIC IMPACT OF RECOMBINANT ACTIVATED FACTOR VII PROPHYLAXIS IN SEVERE GLANZMANN THROMBASTHENIA: A PROSPECTIVE COHORT ANALYSIS FROM SAUDI ARABIA
Aug 11, 2026, 17:16 PM -
COMBINED USE OF CLINICAL OUTCOME ASSESSMENTS AND DIGITAL HEALTH TECHNOLOGY MEASURES: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
CAPLACIZUMAB: HOSPITAL BUDGET IMPACT AND CLINICALLY APPROPRIATE USE AT THE UNIVERSITY PUBLIC HOSPITALS OF PARIS - FRANCE (AP-HP)
Aug 11, 2026, 17:16 PM -
SHOULD COMPARATOR STRATEGY BECOME A DRUG-DEVELOPMENT DECISION, NOT AN HTA DECISION?
Aug 11, 2026, 17:16 PM -
PROJECTED SURVIVAL TO POPULATION AVERAGE LIFE EXPECTANCY WITH PEMBROLIZUMAB IN EARLY-STAGE CANCER IN GREECE: A MODELING STUDY
Aug 11, 2026, 17:16 PM -
CAREGIVER BURDEN OF DISEASE IN A EUROPEAN REAL-WORLD GENERALIZED MYASTHENIA GRAVIS POPULATION AS REPORTED BY PHYSICIANS AND CAREGIVERS
Aug 11, 2026, 17:16 PM -
SYSTEMATIC REVIEW OF THE METHODOLOGY, MODEL STRUCTURE, AND DATA INPUTS OF HEALTH ECONOMIC MODELS EVALUATING SYSTEMIC THERAPIES IN ATOPIC DERMATITIS
Aug 11, 2026, 17:16 PM -
TIME FROM AEMPS AUTHORIZATION TO THE FIRST P&R ASSESSMENT IN 2025 AND LAST AVAILABLE CIPM DECISION IN NEW MEDICINES IN SPAIN
Aug 11, 2026, 17:16 PM -
UTILIZING REAL-WORLD EVIDENCE FROM A LARGE TERTIARY HOSPITAL TO TAILOR BUDGET IMPACT PROJECTIONS FOR NAMD THERAPIES
Aug 11, 2026, 17:16 PM -
ECONOMIC BURDEN OF INTENSIVE CARE UNIT MANAGEMENT FOR DIABETIC KETOACIDOSIS: A PILOT PROSPECTIVE COST ANALYSIS
Aug 11, 2026, 17:16 PM -
BALANCING AMBITION AND REALITY -THE SHIFTING INTERNATIONAL LANDSCAPE OF PERFORMANCE-BASED MANAGED ENTRY AGREEMENTS
Aug 11, 2026, 17:16 PM -
PHARMACEUTICAL SPENDING CAPS ACROSS EUROPE: AN OVERVIEW OF THE CURRENT NATIONAL POLICIES
Aug 11, 2026, 17:16 PM -
HEALTH LITERACY, SHARED DECISION-MAKING AND REASONS FOR LOW MEDICATION ADHERENCE: INSIGHTS FROM A MIXED-METHODS STUDY IN NORWAY
Aug 11, 2026, 17:16 PM -
ADVANCING REIMBURSEMENT CHALLENGES FOR ADVANCED THERAPY MEDICINAL PRODUCTS: A ROOT CAUSE ANALYSIS
Aug 11, 2026, 17:16 PM -
CLOSING GAPS IN REAL-WORLD EVIDENCE: UNLOCKING CLINICAL VALUE FROM UNSTRUCTURED EHR NOTES
Aug 11, 2026, 17:16 PM -
IMPACT OF US MOST-FAVOURED NATION (MFN) PRICING POLICY ON PCPA NEGOTIATION ACTIVITY IN CANADA
Aug 11, 2026, 17:16 PM -
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF SPINAL MUSCULAR ATROPHY IN TURKIYE: A SCOPING REVIEW
Aug 11, 2026, 17:16 PM -
TIME TO TREATMENT INITIATION AND HEALTHCARE RESOURCE UTILISATION AMONG ADULTS WITH NEWLY DIAGNOSED DEPRESSION IN ENGLAND: A REAL-WORLD COHORT STUDY
Aug 11, 2026, 17:16 PM -
ANTIFUNGAL STEWARDSHIP IN A CENTRAL HOSPITAL: GUIDELINE ADHERENCE, CONSUMPTION AND 30-DAY MORTALITY IN 2025
Aug 11, 2026, 17:16 PM -
FAMILY SPILLOVER EFFECTS IN PHARMACOECONOMIC EVALUATION: A SYSTEMATIC REVIEW OF INTERNATIONAL GUIDELINES
Aug 11, 2026, 17:16 PM
